Pulaski Hlth & Rehab Cntr | |
2401 Lee Highway, Pulaski, Virginia 24301 | |
(540) 980-3111 | |
Name | Pulaski Hlth & Rehab Cntr |
---|---|
Location | 2401 Lee Highway, Pulaski, Virginia |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 90 |
Occupancy Rate | 73.56% |
Medicare ID (CCN) | 495294 |
Legal Business Name | Medical Facilities Of America Xix |
Ownership Type | For Profit - Corporation |
NPI Number | 1114591385 |
Organization Name | PULASKI OPERATIONS LLC |
Address | 2401 Lee Hwy N, Pulaski, VA 24301 |
Phone Number | 540-980-3111 |
News Archive
While genetic inheritance is known to play a role in the multifactorial development of most diseases of the heart, there are also a number of clearly diagnosed cardiac conditions which owe their development to quite specific genetic abnormalities. When these genetic disorders affect the integrity of the heart's muscle they are known as a "cardiomyopathy"; when the disorder affects the heart's "excitability", it is known as a "channelopathy".
Up to two-thirds of California's 7 million uninsured residents will become eligible for health insurance coverage when health care reform is implemented in 2014, according to a new policy brief from the UCLA Center for Health Policy Research.
From March 2020, when COVID-19 spread throughout Europe, GPs had to rely on clinical information collected in hospitals, the only official information available, when dealing with potential infections.
Enzon Pharmaceuticals, Inc. today announced the publication of preclinical data demonstrating that PEG-SN38 (EZN-2208), the Company's novel PEGylated DNA topoisomerase I inhibitor, led to significantly greater tumor regression as compared to CPT-11 (irinotecan) in both in vitro and in vivo models of pediatric neuroblastoma.
› Verified 4 days ago
NPI Number | 1760495717 |
Organization Name | MEDICAL FACILITIES OF AMERICA XIX |
Doing Business As | PULASKI HEALTH & REHABILITATION CENTER |
Address | 2401 Lee Hwy N, Pulaski, VA 24301 |
Phone Number | 540-980-3111 |
News Archive
While genetic inheritance is known to play a role in the multifactorial development of most diseases of the heart, there are also a number of clearly diagnosed cardiac conditions which owe their development to quite specific genetic abnormalities. When these genetic disorders affect the integrity of the heart's muscle they are known as a "cardiomyopathy"; when the disorder affects the heart's "excitability", it is known as a "channelopathy".
Up to two-thirds of California's 7 million uninsured residents will become eligible for health insurance coverage when health care reform is implemented in 2014, according to a new policy brief from the UCLA Center for Health Policy Research.
From March 2020, when COVID-19 spread throughout Europe, GPs had to rely on clinical information collected in hospitals, the only official information available, when dealing with potential infections.
Enzon Pharmaceuticals, Inc. today announced the publication of preclinical data demonstrating that PEG-SN38 (EZN-2208), the Company's novel PEGylated DNA topoisomerase I inhibitor, led to significantly greater tumor regression as compared to CPT-11 (irinotecan) in both in vitro and in vivo models of pediatric neuroblastoma.
› Verified 4 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
While genetic inheritance is known to play a role in the multifactorial development of most diseases of the heart, there are also a number of clearly diagnosed cardiac conditions which owe their development to quite specific genetic abnormalities. When these genetic disorders affect the integrity of the heart's muscle they are known as a "cardiomyopathy"; when the disorder affects the heart's "excitability", it is known as a "channelopathy".
Up to two-thirds of California's 7 million uninsured residents will become eligible for health insurance coverage when health care reform is implemented in 2014, according to a new policy brief from the UCLA Center for Health Policy Research.
From March 2020, when COVID-19 spread throughout Europe, GPs had to rely on clinical information collected in hospitals, the only official information available, when dealing with potential infections.
Enzon Pharmaceuticals, Inc. today announced the publication of preclinical data demonstrating that PEG-SN38 (EZN-2208), the Company's novel PEGylated DNA topoisomerase I inhibitor, led to significantly greater tumor regression as compared to CPT-11 (irinotecan) in both in vitro and in vivo models of pediatric neuroblastoma.
› Verified 4 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 10.8 | 14.46 |
Percentage of long-stay residents who lose too much weight | 7.26 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 63.54 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.46 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 5.13 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 1.92 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 4.59 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 2.38 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 97.46 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0.52 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 29.55 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 18.06 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 6.08 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 96.31 | 95.98 |
Percentage of short-stay residents who made improvements in function | 83.19 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 84.21 | 82.93 |
News Archive
While genetic inheritance is known to play a role in the multifactorial development of most diseases of the heart, there are also a number of clearly diagnosed cardiac conditions which owe their development to quite specific genetic abnormalities. When these genetic disorders affect the integrity of the heart's muscle they are known as a "cardiomyopathy"; when the disorder affects the heart's "excitability", it is known as a "channelopathy".
Up to two-thirds of California's 7 million uninsured residents will become eligible for health insurance coverage when health care reform is implemented in 2014, according to a new policy brief from the UCLA Center for Health Policy Research.
From March 2020, when COVID-19 spread throughout Europe, GPs had to rely on clinical information collected in hospitals, the only official information available, when dealing with potential infections.
Enzon Pharmaceuticals, Inc. today announced the publication of preclinical data demonstrating that PEG-SN38 (EZN-2208), the Company's novel PEGylated DNA topoisomerase I inhibitor, led to significantly greater tumor regression as compared to CPT-11 (irinotecan) in both in vitro and in vivo models of pediatric neuroblastoma.
› Verified 4 days ago